Evogene Ltd Ord (EVGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,499 | -8,161 | -5,433 | -2,989 | -14,817 |
| Depreciation Amortization | 2,467 | 1,870 | 1,256 | 905 | 1,852 |
| Accounts receivable | 1,712 | 1,627 | 1,306 | -82 | 179 |
| Accounts payable and accrued liabilities | -1,190 | -1,319 | -1,178 | -1,136 | -967 |
| Other Working Capital | -1,253 | -996 | -597 | -1,798 | -2,613 |
| Other Operating Activity | -1,739 | -3,837 | -2,837 | -82 | -3,334 |
| Operating Cash Flow | $-13,502 | $-10,816 | $-7,483 | $-5,182 | $-19,700 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1 | -7,400 | -3,328 | -2,326 | 10,190 |
| PPE Investments | -57 | -98 | -123 | -122 | -616 |
| Other Investing Activity | 17,796 | 14,973 | 17 | 2 | 48 |
| Investing Cash Flow | $17,738 | $7,475 | $-3,434 | $-2,446 | $9,622 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 2 | N/A |
| Debt Issued | N/A | -10,000 | N/A | N/A | N/A |
| Common Stock Issued | 4,283 | 4,283 | 4,283 | N/A | 123 |
| Other Financing Activity | -10,885 | -629 | -293 | -161 | 4,533 |
| Financing Cash Flow | $-6,602 | $-6,346 | $3,990 | $-159 | $4,656 |
| Exchange Rate Effect | 21 | 12 | 25 | -19 | -49 |
| Beginning Cash Position | 15,301 | 15,301 | 15,301 | 15,301 | 20,772 |
| End Cash Position | 12,956 | 5,626 | 8,329 | 7,495 | 15,301 |
| Net Cash Flow | $-2,345 | $-9,675 | $-6,972 | $-7,806 | $-5,471 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,502 | -10,816 | -7,483 | -5,182 | -19,700 |
| Capital Expenditure | -135 | -129 | -123 | -122 | -626 |
| Free Cash Flow | -13,637 | -10,945 | -7,606 | -5,304 | -20,326 |